Gossamer Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10, 2020
November 06 2020 - 7:07AM
Business Wire
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage
biopharmaceutical company focused on discovering, acquiring,
developing and commercializing therapeutics in the disease areas of
immunology, inflammation and oncology, today announced that it will
report its third quarter 2020 financial results on Tuesday,
November 10, 2020.
In connection with the earnings release, Gossamer’s management
team will host a live conference call and webcast at 4:30 p.m. ET
on Tuesday, November 10, 2020, to discuss the Company’s financial
results and provide a corporate update.
Conference ID: 2879501 Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782 Live Webcast:
https://edge.media-server.com/mmc/p/e6ppaa7u
A replay of the audio webcast will be available for 30 days on
the Investors section of the Company's website,
www.gossamerbio.com.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company
focused on discovering, acquiring, developing and commercializing
therapeutics in the disease areas of immunology, inflammation and
oncology. Its goal is to be an industry leader in each of these
therapeutic areas and to enhance and extend the lives of patients
suffering from such diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201106005093/en/
For Investors and Media: Bryan Giraudo, Chief Financial
Officer Gossamer Bio Investor Relations ir@gossamerbio.com
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Apr 2023 to Apr 2024